Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice

被引：0
|
作者：
Helen Innes
Sheow Lei Lim
Allison Hall
Su Yin Chan
Neeraj Bhalla
Ernest Marshall
机构：
[1] Clatterbridge Centre for Oncology NHS Foundation Trust,
来源：
Supportive Care in Cancer | 2008年 / 16卷
关键词：
MASCC risk index; Low-risk febrile neutropenia; Oral antibiotics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 491
页数：6
相关论文
共 38 条
  • [31] Special Section: The Multinational Association of Supportive Care in Cancer (MASCC) 2020 Clinical Practice Recommendations for the Management of Immune-Mediated Adverse Events from Checkpoint Inhibitors
    Rapoport, Bernardo Leon
    Anderson, Ronald
    SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 6105 - 6105
  • [32] Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network
    Hui, Edwin Pun
    Leung, Linda K. S.
    Poon, Terence C. W.
    Mo, Frankie
    Chan, Vicky T. C.
    Ma, Ada T. W.
    Poon, Annette
    Hui, Eugenie K.
    Mak, So-shan
    Lai, Maria
    Lei, Kenny I. K.
    Ma, Brigette B. Y.
    Mok, Tony S. K.
    Yeo, Winnie
    Zee, Benny C. Y.
    Chan, Anthony T. C.
    SUPPORTIVE CARE IN CANCER, 2011, 19 (10) : 1625 - 1635
  • [33] Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
    Maria E. Suarez-Almazor
    Xerxes Pundole
    Noha Abdel-Wahab
    Douglas B. Johnson
    Dipti Gupta
    Ilya Glezerman
    Tim Cooksley
    Ronald Anderson
    Ada Blidner
    Jennifer Choi
    Michael Dougan
    Pamela Ginex
    Monica Girotra
    Vickie R. Shannon
    Bernardo L. Rapoport
    Supportive Care in Cancer, 2020, 28 : 6159 - 6173
  • [34] Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
    Suarez-Almazor, Maria E.
    Pundole, Xerxes
    Abdel-Wahab, Noha
    Johnson, Douglas B.
    Gupta, Dipti
    Glezerman, Ilya
    Cooksley, Tim
    Anderson, Ronald
    Blidner, Ada
    Choi, Jennifer
    Dougan, Michael
    Ginex, Pamela
    Girotra, Monica
    Shannon, Vickie R.
    Rapoport, Bernardo L.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 6159 - 6173
  • [35] Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendations
    Wong, Henry C. Y.
    Wallen, Matthew P.
    Chan, Adrian Wai
    Dic, Narayanee
    Bonomo, Pierluigi
    Bareham, Monique
    Wolf, Julie Ryan
    van den Hur, Corina
    Fitch, Margaret
    Chow, Edward
    Chan, Raymond J.
    ECLINICALMEDICINE, 2024, 68
  • [36] Methodology for clinical trials involving patients with cancer who have febrile neutropenia: Updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies
    Feld, R
    Paesmans, M
    Freifeld, AG
    Klastersky, J
    Pizzo, PA
    Rolston, KVI
    Rubenstein, E
    Talcott, JA
    Walsh, TJ
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (12) : 1463 - 1468
  • [37] Prediction of outcome in cancer patients with febrile neutropenia:: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10
    Uys, A.
    Rapoport, B. L.
    Fickl, H.
    Meyer, P. W. A.
    Anderson, R.
    EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (06) : 475 - 483
  • [38] Special Section: The Multinational Association of Supportive Care in Cancer (MASCC) 2020 Clinical Practice Recommendations for the Management of Immune-Mediated Adverse Events from Checkpoint InhibitorsGuest editors: Bernardo Leon Rapoport, MD MMed (WITS) and Ronald Anderson PhD
    Supportive Care in Cancer, 2020, 28 : 6105 - 6105
1234